Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05398276 · ClinicalTrials.gov registry record · Phase 2
Behavioral Exposure for Introceptive Tolerance RCT
A Phase 2 study of Anxiety and Cardiac Rehabilitation, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 146
- Enrollment target
- 2
- Study locations
NCT05398276 is a Phase 2 study of Anxiety and Cardiac Rehabilitation that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 146 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05398276, a Phase 2 study of Anxiety and Cardiac Rehabilitation, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 146 participants
- Enrollment target
- 2
- Study locations
Study Summary
Behavioral Exposure for Interoceptive Tolerance (BE-FIT) is a mechanism-informed behavioral intervention to target exercise anxiety. The three primary components of BE-FIT include: (1) exposure to feared bodily sensations and exercise; (2) prevention of safety behavior use before/during/after exercise, and (3) use of a wrist-worn activity monitor for physical activity (PA) feedback and activity goal setting. Evidence from the investigators' Stage I trial indicated that BE-FIT is feasible, acceptable, and safe and produced reductions in exercise anxiety and increased exercise outcomes (short-term moderate-to-vigorous intensity physical activity and steps/day). The investigators' present aim is to conduct a Stage II randomized-controlled trial to further evaluate the efficacy of BE-FIT in decreasing exercise anxiety in cardiac rehabilitation (CR) patients and examine whether changes in this target yield successive changes in exercise adherence outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Health Education Control
- BEHAVIORAL Behavioral Exposure For Introceptive Tolerance
Study Locations (2)
New Jersey
- RWJ Cardiac Rehab at East Brunswick - East Brunswick
- Rutgers Emotion, Health and Behavior Laboratory Department of Psychology - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05398276
The ClinicalTrials.gov registry entry for NCT05398276 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (67% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Health Education Control is the first listed.
NCT05398276 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05398276 about?
NCT05398276 is a clinical study titled "Behavioral Exposure for Introceptive Tolerance RCT". Behavioral Exposure for Interoceptive Tolerance (BE-FIT) is a mechanism-informed behavioral intervention to target exercise anxiety. The three primary components of BE-FIT include: (1) exposure to feared bodily sensations and exercise; (2) prevention of safety behavior use before/during/after exerci...
What is the current status of trial NCT05398276?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2022-05-03. Estimated completion is 2026-07-31.
What conditions does trial NCT05398276 study?
This clinical trial studies the following conditions: Anxiety, Cardiac Rehabilitation, Exercise Sensitivity, Introceptive Exposure.
What interventions are being tested in trial NCT05398276?
The interventions under investigation include: Health Education Control (BEHAVIORAL), Behavioral Exposure For Introceptive Tolerance (BEHAVIORAL).
Who is sponsoring clinical trial NCT05398276?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05398276 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.